Skip to main content

Market Overview

Recap: Motus GI Hldgs Q2 Earnings

Share:

Shares of Motus GI Hldgs (NASDAQ: MOTS) were flat after the company reported Q2 results. Quarterly Results Earnings per share increased 42.31% year over year to ($0.15), which beat the estimate of ($0.21). Revenue of

Shares of Motus GI Hldgs (NASDAQ:MOTS) decreased 4.8% after the company reported Q2 results.

Quarterly Results

Earnings per share increased 42.31% year over year to ($0.15), which beat the estimate of ($0.21).

Revenue of $1,000 decreased by 75.00% from the same period last year, which missed the estimate of $20,000.

Outlook

Motus GI Hldgs hasn't issued any earnings guidance for the time being.

Motus GI Hldgs hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Aug 11, 2020

Time: 04:30 PM

ET Webcast URL: http://public.viavid.com/player/index.php?id=140402

Recent Stock Performance

52-week high: $2.99

52-week low: $0.46

Price action over last quarter: Up 12.26%

Company Description

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company is focused on the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

 

Related Articles (MOTS)

View Comments and Join the Discussion!

Posted-In: Earnings Penny Stocks